Skip to content

RVMD

Revolution Medicines, Inc.

Stock

$205.26+0.78 (+0.38%)Close Sep 30, 2026

Operating income (TTM)−$1.6B

Operating income

PeriodOperating incomeYoY
2025−$1.2B—
2024−$690M—
2023−$487M—
2022−$258M—
2021−$188M—
2020−$111M—
2019−$54M—
2018−$40M—